AJP - Endocrinology and Metabolism, Vol 258, Issue 1 E16-E23, Copyright © 1990 by American Physiological Society

ARTICLES

Use of a variable tracer infusion method to determine glucose turnover in humans

J. M. Molina, A. D. Baron, S. V. Edelman, G. Brechtel, P. Wallace and J. M. Olefsky
Department of Medicine, University of California School of Medicine, La Jolla 92093.

The single-compartment pool fraction model, when used with the hyperinsulinemic glucose clamp technique to measure rates of glucose turnover, sometimes underestimates true rates of glucose appearance (Ra) resulting in negative values for hepatic glucose output (HGO). We focused our attention on isotope discrimination and model error as possible explanations for this underestimation. We found no difference in [3-3H] glucose specific activity in samples obtained simultaneously from the femoral artery and vein (2,400 +/- 455 vs. 2,454 +/- 522 dpm/mg) in 6 men during a hyperinsulinemic euglycemic clamp study where insulin was infused at 40 mU.m-2.min-1 for 3 h; therefore, isotope discrimination did not occur. We compared the ability of a constant (0.6 microCi/min) vs. variable tracer infusion method (tracer added to the glucose infusate) to measure non-steady-state Ra during hyperinsulinemic clamp studies. Plasma specific activity fell during the constant tracer infusion studies but did not change from base line during the variable tracer infusion studies. By maintaining a constant plasma specific activity the variable tracer infusion method eliminates uncertainty about changes in glucose pool size. This overcame modeling error and more accurately measures non-steady-state Ra (P less than 0.001 by analysis of variance vs. constant infusion method). In conclusion, underestimation of Ra determined isotopically during hyperinsulinemic clamp studies is largely due to modeling error that can be overcome by use of the variable tracer infusion method. This method allows more accurate determination of Ra and HGO under non-steady-state conditions.

This article has been cited by other articles:

				C. Hadigan, D. Kamin, J. Liebau, S. Mazza, S. Barrow, M. Torriani, R. Rubin, S. Weise, A. Fischman, and S. Grinspoon Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E289 - E298. [Abstract] [Full Text] [PDF]

				G. Boden, P. Cheung, and C. Homko Effects of Acute Insulin Excess and Deficiency on Gluconeogenesis and Glycogenolysis in Type 1 Diabetes Diabetes, January 1, 2003; 52(1): 133 - 137. [Abstract] [Full Text] [PDF]

				H. Storgaard, X. M. Song, C. B. Jensen, S. Madsbad, M. Bjornholm, A. Vaag, and J. R. Zierath Insulin Signal Transduction in Skeletal Muscle From Glucose-Intolerant Relatives With Type 2 Diabetes Diabetes, December 1, 2001; 50(12): 2770 - 2778. [Abstract] [Full Text] [PDF]

				A. Basu, R. Basu, P. Shah, A. Vella, C. M. Johnson, M. Jensen, K. S. Nair, W. F. Schwenk, and R. A. Rizza Type 2 Diabetes Impairs Splanchnic Uptake of Glucose but Does Not Alter Intestinal Glucose Absorption During Enteral Glucose Feeding: Additional Evidence for a Defect in Hepatic Glucokinase Activity Diabetes, June 1, 2001; 50(6): 1351 - 1362. [Abstract] [Full Text]

				P. H Bisschop, J. de Metz, M. T Ackermans, E. Endert, H. Pijl, F. Kuipers, A. J Meijer, H. P Sauerwein, and J. A Romijn Dietary fat content alters insulin-mediated glucose metabolism in healthy men Am. J. Clinical Nutrition, March 1, 2001; 73(3): 554 - 559. [Abstract] [Full Text] [PDF]

				A. Gastaldelli, A. R. Coggan, and R. R. Wolfe Assessment of methods for improving tracer estimation of non-steady-state rate of appearance J Appl Physiol, November 1, 1999; 87(5): 1813 - 1822. [Abstract] [Full Text] [PDF]